Issued Patents All Time
Showing 76–100 of 198 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9669069 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2017-06-06 |
| 9655352 | Humanized M-CSF mice | Andrew J. Murphy, Sean Stevens, Chozhavendan Rathinam, Elizabeth Eynon, Markus Manz +1 more | 2017-05-23 |
| 9554563 | Genetically modified mice and engraftment | Sean Stevens, Andrew J. Murphy, Richard Flavell, Elizabeth Eynon, Jorge Galan +3 more | 2017-01-31 |
| 9546384 | Methods and compositions for the targeted modification of a mouse genome | David Frendewey, Wojtek Auerbach, Ka-Man Venus Lai, David M. Valenzuela | 2017-01-17 |
| 9540449 | Anti-PCSK9 antibodies with pH-dependent binding characteristics | Nicholas J. Papadopoulos, Andrew J. Murphy, Neil Stahl | 2017-01-10 |
| 9528136 | Methods of modifying eukaryotic cells | Andrew J. Murphy, Margaret Karow, Lynn Macdonald, Sean Stevens, Aris N. Economides +1 more | 2016-12-27 |
| 9388446 | Methods of producing hybrid antibodies | Andrew J. Murphy, Margaret Karow, Lynn Macdonald, Sean Stevens, Aris N. Economides +1 more | 2016-07-12 |
| 9389236 | Isolating cells expressing secreted proteins | James P. Fandl, Gang Chen, Neil Stahl | 2016-07-12 |
| 9382567 | Methods of producing hybrid antibodies | Andrew J. Murphy, Margaret Karow, Lynn Macdonald, Sean Stevens, Aris N. Economides +1 more | 2016-07-05 |
| 9376699 | Methods of producing hybrid antibodies | Andrew J. Murphy, Margaret Karow, Lynn Macdonald, Sean Stevens, Aris N. Economides +1 more | 2016-06-28 |
| 9371553 | Genetically modified mice that produce hybrid antibodies | Andrew J. Murphy, Margaret Karow, Lynn Macdonald, Sean Stevens, Aris N. Economides +1 more | 2016-06-21 |
| 9353394 | Methods of producing hybrid antibodies | Andrew J. Murphy, Margaret Karow, Lynn Macdonald, Sean Stevens, Aris N. Economides +1 more | 2016-05-31 |
| 9301509 | Genetically modified mice and engraftment | Sean Stevens, Andrew J. Murphy, Richard Flavell, Elizabeth Eynon, Jorge Galan +3 more | 2016-04-05 |
| 9254338 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2016-02-09 |
| 9228208 | Methods and compositions for the targeted modification of a genome | David Frendewey, Wojtek Auerbach, Ka-Man Venus Lai, David M. Valenzuela | 2016-01-05 |
| 9139644 | Modified chimeric polypeptides with improved pharmacokinetic properties | Nicholas J. Papadopoulos, Samuel Davis | 2015-09-22 |
| 8847004 | Humanized M-CSF mice | Andrew J. Murphy, Sean Stevens, Chozhavendan Rathinam, Elizabeth Eynon, Markus Manz +1 more | 2014-09-30 |
| 8846402 | Method for genetically modifying isolated non-human mammalian cell by homologous recombination | Aris N. Economides, Andrew J. Murphy, David M. Valenzuela, David Frendewey | 2014-09-30 |
| 8791323 | Hybrid antibodies comprising human variable regions and mouse constant regions produced in a genetically modified mouse | Andrew J. Murphy, Margaret Karow, Lynn Macdonald, Sean Stevens, Aris N. Economides +1 more | 2014-07-29 |
| 8759105 | Method for genetically modifying mouse embryonic stem cell by homologous recombination | Aris N. Economides, Andrew J. Murphy, David M. Valenzuela, David Frendewey | 2014-06-24 |
| 8692052 | Genetically modified mice and engraftment | Sean Stevens, Andrew J. Murphy, Richard Flavell, Elizabeth Eynon, Jorge Galan +3 more | 2014-04-08 |
| 8647842 | Methods for producing a fusion protein capable of binding VEGF | Nicholas J. Papadopoulos, Samuel Davis | 2014-02-11 |
| 8541646 | Genetically modified mice and engraftment | Sean Stevens, Andrew J. Murphy, Richard Flavell, Elizabeth Eynon, Jorge Galan +3 more | 2013-09-24 |
| 8502018 | Methods of modifying eukaryotic cells | Andrew J. Murphy | 2013-08-06 |
| 8445434 | IGF-1 fusion polypeptides and therapeutic uses thereof | David Glass, Thomas Daly, Nicholas J. Papadopoulos | 2013-05-21 |